Our forthcoming conferences and webinars covering a range of Medicines Optimisation issues with SPS and other great speakers and presenters.
Search our library of past events for recordings, presentations, and interviews with speakers, all to inform your practice.

Recommended articles

Whole doses of solid oral dosage forms can be used 'off-label' in place of oral suspensions. This includes use for Group A streptococcal infections
Temperature changes can affect medicines. Learn to manage temperature and act when temperature is outside the intended range.
Advice on using written instructions for the administration of 'flu vaccinations to healthcare staff.
There is a risk of severe harm or death if PN is unintentionally infused too rapidly in babies. Healthcare professionals need to ensure safe practice.
Constipation in people taking clozapine can be fatal. Guidance on preventing and managing constipation in these individuals is described.
Opioid analgesics may be used at any stage of pregnancy at the lowest effective dose for the short-term relief of pain when other analgesics are not effective
Healthcare professionals involved in the use of metolazone need to be aware of the differences between licensed and unlicensed products to ensure safe care
Healthcare professionals who use vitamin D should be aware of the risks of toxicity and safe practice principles which may prevent patient harm
A patient safety alert highlighted the risks of giving inappropriate doses of naloxone. This page guides on using appropriate intravenous doses.
Safety risks and mitigation strategies are described to reduce the risk of errors with intravenous paracetamol in neonates, infants, and children.


Information and guidance from across SPS on pharmaceutical aspects of COVID-19 vaccines’ use
Guidance for Chief Pharmacists and supporting documents to achieve Institutional Readiness and deployment of COVID-19 Treatments
Resources and tools to support Medicines Optimisation activities during the COVID-19 pandemic

Recommended in PGDs

National PGD templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.
A step by step guide to help organisations and individuals navigate all stages of the PGD development process
Guidance on when PGDs should not be used and advice on alternative mechanisms for supply and administration of medicines


Latest information on supply issues, actions to take, alternatives to use, and expected resolution dates. Content provided by DHSC and CMU.
Our annual Prescribing Outlook outputs support planning, implementation and budget planning for medicines every year.
Regularly updated new medicines material, in addition to our annual outputs
Regularly updated patent expiry material, in addition to our annual outputs
Regularly updated biosimilars material, in addition to our annual outputs. Includes specific information on ranibizumab for ocular use.

Recommended for primary care

Summarised recommendations and guidance for medicines requiring monitoring to save you time when you're making monitoring decisions with patients
All our advice on using medicines safely and effectively in patients with swallowing difficulties
All our training and guidance to help decision making about the use of medicines in breastfeeding
All our training and guidance to help decision making about the use of medicines in pregnancy